Hai-Feng Wang Selected Research

Hai-Feng Wang Research Topics

Disease

11	Neoplasms (Cancer) 07/2022 - 01/2012
7	Prostatic Neoplasms (Prostate Cancer) 09/2023 - 05/2015
4	Pain (Aches) 10/2023 - 02/2012
4	Urinary Bladder Neoplasms (Bladder Cancer) 04/2016 - 01/2012
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2023 - 06/2015
3	Pneumonia (Pneumonitis) 12/2022 - 10/2022
3	Breast Neoplasms (Breast Cancer) 12/2020 - 11/2014
2	Fever (Fevers) 10/2022 - 02/2012
2	Wounds and Injuries (Trauma) 04/2021 - 11/2008
2	Ischemia 01/2018 - 03/2007
2	Carcinoma (Carcinomatosis) 04/2016 - 01/2012
2	Infections 07/2012 - 06/2005
2	Schizophrenia (Dementia Praecox) 10/2011 - 03/2009
1	Rupture 12/2023
1	Lung Neoplasms (Lung Cancer) 07/2023
1	COVID-19 12/2022
1	Stroke (Strokes) 10/2022
1	Hematuria 06/2022
1	Dysuria 02/2022
1	Neuralgia (Stump Neuralgia) 11/2021
1	Inflammation (Inflammations) 10/2021
1	Intervertebral Disc Displacement (Herniated Disc) 04/2021
1	Low Back Pain (Lumbago) 04/2021
1	Erectile Dysfunction 01/2021
1	Urinary Incontinence 01/2021
1	Starvation 11/2020
1	Pancreatitis 08/2020
1	Hepatocellular Carcinoma (Hepatoma) 03/2020
1	Margins of Excision 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Sarcopenia 01/2020
1	Adenocarcinoma of Lung 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2019
1	Leukemia 09/2018
1	Alzheimer Disease (Alzheimer's Disease) 11/2016
1	Cognitive Dysfunction 11/2016
1	Dementia (Dementias) 06/2016
1	Heart Neoplasms 07/2015
1	Hepatoblastoma 01/2015

Drug/Important Bio-Agent (IBA)

6	MicroRNAs (MicroRNA)IBA 12/2020 - 01/2017
3	Prostate-Specific Antigen (Semenogelase)IBA 09/2023 - 02/2022
3	Peptides (Polypeptides)IBA 12/2020 - 01/2012
2	LigandsIBA 01/2023 - 06/2017
2	LipopolysaccharidesIBA 10/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 08/2020 - 05/2015
2	Long Noncoding RNAIBA 01/2020 - 05/2015
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2016 - 06/2016
2	Proteins (Proteins, Gene)FDA Link 02/2012 - 03/2011
1	COVID-19 VaccinesIBA 12/2022
1	Shen-FuIBA 10/2022
1	xingnaojingIBA 10/2022
1	XuebijingIBA 10/2022
1	tanreqingIBA 10/2022
1	radix ophiopogonis drug combination radix ginseng fructus schizandrae (Shen Mai)IBA 10/2022
1	gallium 68 PSMA-11IBA 07/2022
1	3' Untranslated Regions (3' UTR)IBA 10/2021
1	LuciferasesIBA 10/2021
1	vMIP-IIIBA 12/2020
1	Phosphates (Orthophosphate)IBA 11/2020
1	NitrogenIBA 11/2020
1	NitratesIBA 11/2020
1	Transcription Factors (Transcription Factor)IBA 11/2020
1	Phosphorus (Red Phosphorus)IBA 11/2020
1	Human immunodeficiency virus 1 reverse transcriptaseIBA 10/2020
1	TriterpenesIBA 03/2020
1	Competitive Endogenous RNAIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 09/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2017
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 06/2017
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 06/2017
1	CXCR4 Receptors (CXCR4 Receptor)IBA 06/2017
1	4-sulfoxyphenylacetyl dehydroalanine (AD 19)IBA 11/2016
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2016
1	Antihypertensive Agents (Antihypertensives)IBA 06/2016
1	Angiotensin Receptor AntagonistsIBA 06/2016
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 04/2016
1	pirarubicinIBA 07/2015
1	tegafur-gimeracil-oteracilIBA 07/2015
1	pyrimidineIBA 06/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2015
1	Matrix Metalloproteinases (MMPs)IBA 01/2015
1	N 30IBA 01/2015

Therapy/Procedure

6	Therapeutics 10/2022 - 01/2012
4	Prostatectomy (Retropubic Prostatectomy) 07/2022 - 01/2019
3	Radiotherapy 01/2023 - 01/2021
2	Length of Stay 10/2022 - 01/2020
1	Solid-State Lasers 12/2023
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 12/2023
1	Local Anesthesia 10/2023
1	Drug Therapy (Chemotherapy) 07/2023
1	Injections 10/2022
1	Aftercare (After-Treatment) 11/2021
1	Pedicle Screws 04/2021
1	Highly Active Antiretroviral Therapy (HAART) 10/2020
1	Operative Time 01/2020